Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Abstract

New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervous system lesions in space and time has been simplified, and in some circumstances dissemination in space and time can be established by a single scan. These revisions simplify the Criteria, preserve their diagnostic sensitivity and specificity, address their applicability across populations, and may allow earlier diagnosis and more uniform and widespread use. Ann Neurol 2011

Shown for reading. Its publisher allows quoting it, not republishing it.

References 91

1. 1.

   Schumacher FA, Beeve GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552-568.

   Not in our library10.1111/j.1749-6632.1965.tb20235.x

2. 2.

   Poser CM, Paty DW, Scheinberg LC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;1:227-231.

   Not in our library10.1002/ana.410130302

3. 3.

   Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology. 1988;38:180-185.

   Not in our library10.1212/wnl.38.2.180

4. 4.

   Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite MS. Brain. 1997;120:2059-2069.

   Not in our library10.1093/brain/120.11.2059

5. 5.

   Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. 1988;38:1822-1825.

   Not in our library10.1212/wnl.38.12.1822

6. 6.

   Tintoré M, Rovira A, Martinéz M, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol. 2000;21:702-706.

   Not in our library

7. 7.

   Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol. 2000;6:831-835.

   Not in our library

8. 8.

   McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121-127.

   Not in our library10.1002/ana.1032

9. 9.

   Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.”. Ann Neurol. 2005;58:840-846.

   Not in our library10.1002/ana.20703

10. 10.

    Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol. 2002;52:47-53.

    Not in our library10.1002/ana.10240

11. 11.

    MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology. 2002;59:998-1005.

    Not in our library10.1212/wnl.59.7.998

12. 12.

    Barkhof F, Rocca M, Francis G, et al. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta-1a. Ann Neurol. 2003;53:718-724.

    Not in our library10.1002/ana.10551

13. 13.

    Tintoré M, Rovira A, Rio J, et al. New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode. Neurology. 2003;60:27-30.

    Not in our library10.1212/wnl.60.1.27

14. 14.

    Charil A, Yousry TA, Rovaris M, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation.”. Lancet Neurol. 2006;10:841-852.

    Not in our library10.1016/s1474-4422(06)70572-5

15. 15.

    Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14:1157-1174.

    Not in our library10.1177/1352458508096878

16. 16.

    Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106-2012.

    Not in our library10.1016/s0140-6736(04)17551-x

17. 17.

    Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473-477.

    Not in our library10.1084/jem.20050304

18. 18.

    Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology. 2010;75:1423-1427.

    Not in our library10.1212/wnl.0b013e3181f8832e

19. 19.

    Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805-815.

    Not in our library10.1016/s1474-4422(07)70216-8

20. 20.

    Carroll WM, Fujihara K. Neuromyelitis optica. Curr Treat Options Neurol. 2010;12:244-255.

    Not in our library10.1007/s11940-010-0071-z

21. 21.

    Hawkes CH, Giovannoni G. The McDonald Criteria for multiple sclerosis: time for clarification. Mult Scler. 2010;16:566-575.

    Not in our library10.1177/1352458510362441

22. 22.

    Swanton JK, Rovira A, Tintoré M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 2007;6:677-686.

    Not in our library10.1016/s1474-4422(07)70176-x

23. 23.

    Rovira A, Swanton J, Tintoré M, et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol. 2009;5:287-292.

    Not in our library10.1001/archneurol.2009.49

24. 24.

    Montalban X, Tintoré M, Swanton J, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 2010;74:427-434.

    Not in our library10.1212/wnl.0b013e3181cec45c

25. 25.

    McHugh JC, Galvin PL, Murphy RP. Retrospective comparison of the original and revised McDonald Criteria in a general neurology practice in Ireland. Mult Scler. 2008;14:81-85.

    Not in our library10.1177/1352458507081169

26. 26.

    Albertyn C, O'Dowd S, McHugh J, Murphy R. Compliance with McDonald criteria and red flag recognition in a general neurology practice in Ireland. Mult Scler. 2010;16:678-684.

    Not in our library10.1177/1352458510368688

27. 27.

    Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2006;77:830-833.

    Not in our library10.1136/jnnp.2005.073247

28. 28.

    Tur C, Tintoré M, Rovira A, et al. Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult Scler. 2008;14:631-635.

    Not in our library10.1177/1352458507087327

29. 29.

    Heun R, Kappos L, Bittkau S, et al. Magnetic resonance imaging and early diagnosis of MS. Lancet. 1988;2:1202-1203.

    Not in our library10.1016/s0140-6736(88)90277-2

30. 30.

    Tas MW, Barkhof F, van Walderveen MA, et al. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. Am J Neuroradiol. 1995;16:259-264.

    Not in our library

31. 31.

    Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62:865-870.

    Not in our library10.1001/archneur.62.6.865

32. 32.

    Masiuan J, Alvarez-Cermeño JC, García-Barragán N, et al. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology. 2006;66:576-578.

    Not in our library10.1212/01.wnl.0000198253.35119.83

33. 33.

    Tintoré M, Rovira A, Río J, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology. 2008;70:1079-1083.

    Not in our library10.1212/01.wnl.0000280576.73609.c6

34. 34.

    Polman CH, Wolinsky JS, Reingold SC. Multiple sclerosis diagnostic criteria: three years later. Mult Scler. 2005;11:5-12.

    Not in our library10.1191/1352458505ms1135oa

35. 35.

    Hawker K, O'Connor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol. 2009;66:460-471.

    Not in our library10.1002/ana.21867

36. 36.

    Montalban X, Sastre-Garriga J, Filippi M, et al. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler. 2009;15:1459-1465.

    Not in our library10.1177/1352458509348422

37. 37.

    Absinta MA, Rocca MA, Moiola L, et al. Brain macro- and microscopic damage in patients with pediatric MS. J Neuro Neurosurg Psychiatry. 2010;81:1357-1362.

    Not in our library10.1136/jnnp.2010.205682

38. 38.

    Callen DJA, Shroff MM, Branson HM, et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology. 2009;72:961-967.

    Not in our library10.1212/01.wnl.0000338629.01627.54

39. 39.

    Chong HT, Kira J, Tsai CP, et al. Proposed modifications to the McDonald criteria for use in Asia. Mult Scler. 2009;15:887-888.

    Not in our library10.1177/1352458509104587

40. 40.

    Chong HT, Li PCK, Singhal BJ, et al. Proposed modification to McDonald diagnostic criteria for Asians with multiple sclerosis. Neurol Asia. 2006;11:87-90.

    Not in our library

41. 41.

    Lana-Piexoto MA. Devic's neuromyelitis optica: a critical review. Arq Neuropsiquiatr. 2008;66:120-138.

    Not in our library10.1590/s0004-282x2008000100034

42. 42.

    Yeh EA, Chitnis T, Krupp L, et al. Pediatric multiple sclerosis. Nat Rev Neurol. 2009;5:621-631.

    Not in our library10.1038/nrneurol.2009.158

43. 43.

    Banwell B, Ghezzi A, Bar-Or A, et al. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol. 2007;6:887-902.

    Not in our library10.1016/s1474-4422(07)70242-9

44. 44.

    Venkateswaran S, Banwell B. Pediatric multiple sclerosis. Neurologist. 2010;16:92-105.

    Not in our library10.1097/nrl.0b013e3181c923d5

45. 45.

    Hahn JS, Pohl D, Rensel M, et al. Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurology. 2007;68(suppl 2):S13-S22.

    Not in our library10.1212/01.wnl.0000259403.31527.ef

46. 46.

    Ghassemi R, Antel SB, Narayanan S, et al. Lesion distribution in children with clinically isolated syndromes. Ann Neurol. 2008;63:401-405.

    Not in our library10.1002/ana.21322

47. 47.

    Waubant E, Chabas D, Okuda DT, et al. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol. 2009;66:967-971.

    Not in our library10.1001/archneurol.2009.135

48. 48.

    Yeh EA, Weinstock-Guttman B, Ramanathan M, et al. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain. 2009;132(pt 12):3392-3400.

    Not in our library10.1093/brain/awp278

49. 49.

    Chabas D, Castillo-Trivino T, Mowry EM, et al. Vanishing MS T2-bright lesions before puberty. Neurology. 2008;71:1090-1093.

    Not in our library10.1212/01.wnl.0000326896.66714.ae

50. 50.

    Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for elapse after acute CNS inflammatory demyelination in childhood. Brain. 2004;127:1942-1947.

    Not in our library10.1093/brain/awh218

51. 51.

    Ketelslegers IA, Neuteboom RF, Boon M, et al. A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology. 2010;74:1412-1415.

    Not in our library10.1212/wnl.0b013e3181dc138b

52. 52.

    Verhey L, Branson HM, Makhija M, et al. Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study. Neuroradiology. 2010;52:1153-1162.

    Not in our library10.1007/s00234-010-0755-9

53. 53.

    Krupp LB, Banwell B, Tenembaum S, et al. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(suppl 2):S7-S12.

    Not in our library10.1212/01.wnl.0000259422.44235.a8

54. 54.

    Callen DJA, Shroff MM, Branson HM, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology. 2009;72:968-973.

    Not in our library10.1212/01.wnl.0000338630.20412.45

55. 55.

    Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in Japanese. Brain. 2007;130:1206-1223.

    Not in our library10.1093/brain/awm027

56. 56.

    Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007;130:1235-1243.

    Not in our library10.1093/brain/awm062

57. 57.

    Osoegawa M, Kira J, Fukazawa T, et al. Temporal changes and geographic differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler. 2009;15:159-173.

    Not in our library10.1177/1352458508098372

58. 58.

    Nakashima I, Fukazawa T, Ota K, et al. Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features. J Neurol. 2007;254:488-492.

    Not in our library10.1007/s00415-006-0400-z

59. 59.

    Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485-1489.

    Not in our library10.1212/01.wnl.0000216139.44259.74

60. 60.

    Sato D, Fujihara K. NMO without typical opticospinal phenotype. Mult Scler. 2010;16:1154-1155.

    Not in our library10.1177/1352458510377908

61. 61.

    Smith CH, Waubant E, Langer-Gould A. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population. J Neuroopthalmol. 2009;29:104-106.

    Not in our library10.1097/wno.0b013e3181a63606

62. 62.

    Awad A, Hemmer B, Hartung HP, et al. Analysis of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. J Neuroimmunol. 2010;219:1-7.

    Not in our library10.1016/j.jneuroim.2009.09.002

63. 63.

    Brettschneider J, Jaskowski TD, Tumani H, et al. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. J Neuroimmunol. 2009;217:95-101.

    Not in our library10.1016/j.jneuroim.2009.07.017

64. 64.

    Quintana FJ, Farez MF, Viglietta V, et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A. 2008;105:18889-18894.

    Not in our library10.1073/pnas.0806310105

65. 65.
    Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls · 2009

    No notice
66. 66.

    Frohman EM, Balcer LJ, Calabresi PA. Multiple sclerosis: can retinal imaging accurately detect optic neuritis? Nat Rev Neurol. 2010;6:125-126.

    Not in our library10.1038/nrneurol.2010.13

67. 67.

    Bø L, Vedeler CA, Nyland H, et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler. 2003;9:323-331.

    Not in our library10.1191/1352458503ms917oa

68. 68.

    Bø L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003;62:723-732.

    Not in our library10.1093/jnen/62.7.723

69. 69.

    Geurts JJ, Pouwels PJ, Uitdehaag BM, et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology. 2005;236:254-260.

    Not in our library10.1148/radiol.2361040450

70. 70.

    Calabrese M, De Stefano N, Atzori M, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol. 2007;64:1416-1422.

    Not in our library10.1001/archneur.64.10.1416

71. 71.

    Nelson F, Poonawalla A, Hou P, et al. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler. 2008;14:1214-1219.

    Not in our library10.1177/1352458508094644

72. 72.

    Nelson F, Poonawalla A, Hou P, et al. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. Am J Neuroradiol. 2007;28:1645-1649.

    Not in our library10.3174/ajnr.a0645

73. 73.

    Calabrese M, Rocca MA, Atzori M, et al. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology. 2009;72:1330-1336.

    Not in our library10.1212/wnl.0b013e3181a0fee5

74. 74.

    Calabrese M, Rocca MA, Atzori M, et al. A 3-year magnetic resonance imaging study of cortical lesions in relapsing-onset MS. Ann Neurol. 2010;67:376-383.

    Not in our library10.1002/ana.21906

75. 75.

    Filippi M, Rocca MA, Calabrese M, et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology. 2010;75:1988-1994.

    Not in our library10.1212/wnl.0b013e3181ff96f6

76. 76.

    Wattjes MP, Harzheim M, Lutterbey GG, et al. Does high field MRI allow an earlier diagnosis of multiple sclerosis? J Neurol. 2008;255:1159-1163.

    Not in our library10.1007/s00415-008-0861-3

77. 77.

    Wattjes MP, Barkhof F. High field MRI in the diagnosis of multiple sclerosis: high field-high yield? Neuroradiology. 2009;51:279-292.

    Not in our library10.1007/s00234-009-0512-0

78. 78.

    Stankiewicz JM, Neema M, Alsop DC, et al. Spinal cord lesions and clinical status in multiple sclerosis: a 1.5 T and 3T MRI study. J Neurol Sci. 2009;279:99-105.

    Not in our library10.1016/j.jns.2008.11.009

79. 79.

    Wattjes MP, Lutterbey GG, Gieseke J, et al. Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis. Am J Neuroradiol. 2007;28:54-59.

    Not in our library

80. 80.

    Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol. 2008;64:707-713.

    Not in our library10.1002/ana.21582

81. 81.

    Mainero C, Benner T, Radding A, et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology. 2009;73:941-948.

    Not in our library10.1212/wnl.0b013e3181b64bf7

82. 82.

    Kangarlu A, Bourekas EC, Ray-Chaudhury A, Rammohan KW. Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. Am J Neuroradiol. 2007;28:262-266.

    Not in our library

83. 83.

    Kollia K, Maderwald S, Putzki N, et al. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. Am J Neuroradiol. 2009;30:699-702.

    Not in our library10.3174/ajnr.a1434

84. 84.

    Filippi M. In-vivo tissue characterization of multiple sclerosis and other white matter diseases using magnetic resonance based techniques. J Neurol. 2001;248:1019-1029.

    Not in our library10.1007/s004150170020

85. 85.

    Rocca M, Agosta F, Sormani MP, et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol. 2008;255:683-691.

    Not in our library10.1007/s00415-008-0776-z

86. 86.

    LeBrunn C, Bensa C, Debouverie M, et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid and visual evoked potential. Arch Neurol. 2009;66:841-846.

    Not in our library10.1001/archneurol.2009.119

87. 87.

    Sellner J, Schirmer L, Hemmer B, Mühlau M. The radiologically isolated syndrome: take action when the unexpected is uncovered? J Neurol. 2010;257:1602-1611.

    Not in our library10.1007/s00415-010-5601-9

88. 88.

    Okuda DT, Mowr EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72:800-805.

    Not in our library10.1212/01.wnl.0000335764.14513.1a

89. 89.

    Siva A, Saip S, Altintas A, et al. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler. 2009;15:918-927.

    Not in our library10.1177/1352458509106214

90. 90.

    Carmosino MJ, Brosseau KM, Arciniegas DB, Corboy JR. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral. Arch Neurol. 2005;62:585-590.

    Not in our library10.1001/archneur.62.4.585

91. 91.

    Sormani MP, Tintoré M, et al. The Will Rogers phenomenon in multiple sclerosis. Ann Neurol. 2008;64:428-433.

    Not in our library10.1002/ana.21464

Cited by papers we hold 80

• Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment · 2024
  No notice
• Incidence of Developmental Venous Anomalies in Patients With Multiple Sclerosis: A 3 Tesla MRI Study · 2022
  Not checked
• Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis. · 2022
  Not checked
• KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19 · 2022
  No notice
• Kynurenines and Neurofilament Light Chain in Multiple Sclerosis · 2021
  Not checked
• Validation of Two Kinetic Assays for the Quantification of Endotoxin in Human Serum · 2021
  Not checked
• Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis · 2021
  Not checked
• Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial · 2021
  Not checked
• Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial · 2021
  Not checked
• Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment · 2021
  Not checked
• Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy · 2020
  Not checked
• Rotating frame MRI relaxations as markers of diffuse white matter abnormalities in multiple sclerosis · 2020
  Not checked
• Epidemiology of multiple sclerosis in Central Europe, update from Hungary · 2020
  Not checked
• Fatigue and Suicidal Ideation in People With Multiple Sclerosis: The Role of Social Support · 2020
  Not checked
• Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis · 2020
  Not checked
• Design, Development, and Testing of an App for Dual-Task Assessment and Training Regarding Cognitive-Motor Interference (CMI-APP) in People With Multiple Sclerosis: Multicenter Pilot Study · 2020
  Not checked
• A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain · 2020
  Not checked
• Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome · 2020
  Not checked
• Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod · 2020
  Not checked
• Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics. · 2020
  Not checked

and 60 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.